Veracyte expands into Brazil; Sequenom's revenue jumps 20%;

@FierceMedDev: Veracyte is advancing into Brazil with its thyroid cancer Dx through an interesting new partnership. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Updated with statement from company: Intuitive gets out from under FDA warning letter. Report | Follow @VarunSaxena2

@EmilyWFierce: More bad news for Endo: Company posted net losses of $436.9M and a drop in pharma sales in Q1. FiercePharma story | Follow @EmilyWFierce

@MichaelGFierce: ICYMI from FierceDrugDelivery: Oramed's oral insulin PhIIa details show a compromised study, and shares continue to fall. Article | Follow @MichaelGFierce

> Veracyte ($VCYT) inked a deal to get its thyroid cancer diagnostic into Brazil. Story

> Cleveland's Arteriocyte secured the FDA's blessing to launch a U.S. trial of its Magellan Bio-Bandage. News

> Sequenom ($SQNM) boosted its quarterly revenue by 20% year-over-year, bringing in $46.3 million thanks to increasing demand for its prenatal tests. Results

Biotech News

@FierceBiotech: EuroBiotech: Britain fearful of Pfizer future, UCB on the hunt for antibody partners, Novartis snubs Transgene. Report | Follow @FierceBiotech

@JohnCFierce: Vintafolide is toast, fails PhIII. Release | Follow @JohnCFierce

@DamianFierce: $AGN says it's "golf-course deprived" but stays mum on rumored bouncey castle, ski ball machine and raw juice bar. More from the WSJ | Follow @DamianFierce

@EmilyMFierce: Looking to sales growth, Merck rolls out vaccine adherence plan. More from FierceVaccines | Follow @EmilyMFierce

> FDA rejects The Medicines Co.'s clot-buster, sending cangrelor back to the clinic. News

> Pfizer jumps on the microbiome bandwagon with expansive Second Genome deal. More

> AstraZeneca bars the door, but Pfizer presses on with $106B buyout bid. Report

> Ex-champ Vertex dumps hep C, but shares spike on positive CF results. Story

Pharma News

@FiercePharma: Top-read special report: The top 10 pharma companies by 2013 revenue. Feature | Follow @FiercePharma

@TracyStaton: ICYMI this week: Allergan to propose to Shire again, but does Irish beauty want to get engaged? Story | Follow @TracyStaton

@EricPFierce: Taro expanding a plant in Canada. Provincial government will kick in about $10M of the $247M investment. More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Takeda wins $70M from Japan to bump up H5N1 vaccine production. FierceVaccines story | Follow @CarlyHFierce

> Pfizer's approach may turn hostile after AZ rejects second offer. Story

> Sun is closing Caraco plant in Detroit and whacking nearly 180 jobs. Article

> Reports: Bayer closing in on deal for Merck OTC unit with Reckitt out of the way. More

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.